Health-Holland

The power of public- private partnerships Thinking out-of-the-box, directness, and willingness to collaborate and exchange knowledge are key characteristics that give the Dutch a leading position in public-private research and ‘open innovation’. The Dutch approach is: ‘It’s not what we do for you, it’s what we do with you, that counts.’ This lays a firm foundation for companies, NGOs, knowledge institutions, and government, upon which to build; the so-called ‘quadruple-helix’ approach – a formalized structure created to set out specific guidelines, common policies and goals. Pragmatic solutions Dutch Public-Private Partnerships (PPPs) receive worldwide acclaim, especially in the areas of oncology, medical technology, bio-banks and vaccines. PPPs such as the Netherlands Genomics Initiative, CTMM and TI Pharma (both merged into Lygature) have set international standards. The entire healthcare-chain is typified by a strong inter-disciplinary approach that leads to pragmatic, holistic solutions - from bench to patient. “To develop vaccines against pathogens of global concern, such as Ebola, HIV and AMR bacteria, partnerships are essential. In the Netherlands, Janssen Vaccines can collaborate with many high- ranking academic institutes, and it is a breeding ground for biotech start-ups. This creates a climate of cooperation that allows us to stay a frontrunner in our field.” Johan van Hoof , Global Head of Vaccines R&D at Janssen 16